The Minister of Industry, Tourism and Trade, Reyes Maroto, has announced that the next health PERTE will include the production of essential drugs in Spain. An injection of capital that, as explained, will aim to “create a strategic reserve of these resources” for future situations of health crisis.
During the celebration of the ‘II Health Observatory Symposium: The Lessons of Covid-19’, organized by EL ESPAÑOL and Invertia, the head of the Industry portfolio has expanded some of the main lines of the next Strategic Project for Economic Recovery and Transformation (PERTE) proposed by the Government of Spain.
“It is aimed at encouraging biomedical research and adding basic research to the clinic and consolidating Spain’s leadership in this area. The local production of essential drugs that would suppose a strategic reserve of these resources in situations of sanitary crisis “, has added.
Thus, this PERTE will be aimed at the “direct” application of the creation of knowledge in the field of health, making Spain “a leader at the European level”. “It is a great opportunity to promote biomedical research from a triple perspective: health, economic and social.”
“The objective of PERTE will be to incorporate innovative advances in biotechnology, prevention, diagnosis, treatment and clinical management of patients,” added the Minister of Industry.
In the same way, the minister has also advanced some of the lines of the new Plan Profarma (in collaboration with the Ministry of Health) in which your department is working.
In this regard, Maroto has opted to continue promoting all those activities that “are fundamental” such as investment in new industrial plants or new technologies for production “promoting research, development and innovation”.
Taking advantage of the fact that he was in front of some of the most important representatives of the sector, Maroto has announced other of the “transversal investments” that his department has launched.
As funds to support productive investment that have a budget of 600 million euros or two calls to support innovation in digitization “with an investment of close to 200 million euros”.
A “key” sector
“The pharmaceutical industry is going to be a key industrial sector in the era post-Covid“, the minister reaffirmed, assuring that” it generates wealth and provides stable and quality employment. “Maroto has also insisted on accelerating a State Pact for Industry because it is a” good time “to address it and strengthen the productive capacities of the industry .
According to data from the ministry, the pharmaceutical industry has a turnover of 15,000 million euros, employs 43,000 people “with stable and equal employment” and is “one of the three most productive industries in Spain”.
Regarding the strategic plan of the pharmaceutical industry, Maroto has assured that he works with Carolina Darias, Minister of Health; and Diana Morant, Minister of Science; to “define in the long term” the contribution of the pharmaceutical industry to economic recovery.
A project that also shares the objectives of the European pharmaceutical strategy that “seeks to guarantee access to medicines and improve the mechanisms for preparing and responding to crises”.
Follow the topics that interest you